Ligand Pharmaceuticals Inc (LGND)
Capital Expenditure
-$26.00K
Quarterly · Period ending: · USD
LGND Capital Expenditure
Latest reported-$26.00Kperiod ending
Latest reported-$26.00Kperiod ending
LGND Quarterly CapEx (-$200.00K → -$26.00K)
Quarterly CapEx
High-resolution chart · PNG
LGND capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -26,000 | |
| -228,000 | |
| -9,000 | |
| -15,000 | |
| -214,000 | |
| -214,000 | |
| -712,000 | |
| -14,241,000 | |
| -2,139,000 | |
| -105,000 | |
| -417,000 | |
| -487,000 | |
| -203,000 | |
| -2,414,000 | |
| -2,131,000 | |
| -5,289,000 | |
| -6,588,000 | |
| -4,875,000 | |
| -2,195,000 | |
| -1,772,000 | |
| -4,794,000 | |
| -3,404,000 | |
| -4,458,000 | |
| -2,037,000 | |
| -791,000 | |
| 0 | |
| -2,553,000 | |
| 0 | |
| 0 | |
| 0 | |
| -10,887,000 | |
| 0 | |
| 0 | |
| -1,000,000 | |
| -1,936,000 | |
| -21,000 | |
| -112,000 | |
| -5,085,000 | |
| -1,789,000 | |
| -2,186,000 | |
| -18,663,000 | |
| -5,684,000 | |
| -1,865,000 | |
| -1,278,000 | |
| -4,463,000 | |
| -3,257,000 | |
| -2,563,000 | |
| -267,000 | |
| -45,000 | |
| -1,624,000 | |
| -1,003,000 | |
| -205,000 | |
| -3,692,000 | |
| -37,000 | |
| -8,011,000 | |
| -372,000 | |
| -242,000 | |
| -19,000 | |
| 38,000 | |
| -111,000 | |
| 0 | |
| -5,000 | |
| 1,375,000 | |
| -5,000 | |
| -1,384,000 | |
| -56,000 | |
| 15,000 | |
| -217,000 | |
| -106,000 | |
| -214,000 | |
| -41,000 | |
| -69,000 | |
| -189,000 | |
| -196,000 | |
| -71,000 | |
| -38,000 | |
| -245,000 | |
| -86,000 | |
| -191,000 | |
| -918,000 | |
| -484,000 | |
| -190,000 | |
| -268,000 | |
| -34,183,000 | |
| -548,000 | |
| -597,000 | |
| -761,000 | |
| -822,000 | |
| -1,069,000 | |
| -952,000 | |
| -1,542,000 | |
| -796,000 | |
| -207,000 | |
| -238,000 | |
| -281,000 | |
| -709,000 | |
| -676,000 | |
| -1,495,000 | |
| -443,000 | |
| -191,000 |